.......
GAVI Alliance Governance C ommittee Meeting
14 May 2012
Gov -201 2-Mtg -2 1




GAVI Alliance Governance Committee Meeting
14 May 2012
Washington, DC USA


FINAL M INUTES



1. Chair?s report

1.1 Finding a quorum of members present, the meeting commenced at 11.04
Washington time on 14 May 201 2. Geeta Rao Gupta , Governance Committee
Chair , chaired the meeting .

1.2 Standing declarations of interest were tabled to the Committee (Doc 1a in the
Committee pack). Alan Hinman noted his institution had received a grant from
Novartis to research Measles vaccine , but did not anticipate that would cause
a conflict at this meeting. Nicholas Alipui noted that he had no personal/
financial interests that needed to be declared.

1.3 The Committee noted the minutes of its meeti ng on 15 November 2011 (Doc
1b), which were approved by no -objection on 25 March 2012 , and reviewed
the minutes of its meeting on 10 April 2012 (Doc 1c).

1.4 Next the Committee reviewed its action sheet (Doc 1d) and its forward
workplan (Doc 1e).

Decision One

The GAVI Alliance Governance Committee:

? Approved the minutes of its meeting on 10 April 2012.

------

2. Follow -up to the Oslo retreat on governance matters

2.1 The Chair led a discussion on a number of governance -related matters
stemming from the Board?s retreat in Oslo on 1 6-17 April 2012 (Doc 2).




 

The Global Measles and Rubella Strategic Plan 2012-2020 by American Red Cross/CDC/UN Foundation/UNICEF/WHO.

GAVI Alliance Programme and Policy Committee Meeting
23 -24 April 2012

PPC -2012 -Mtg -1 1




GAVI Alliance Programme and Policy Committee Meeting
23 -24 April 2012
GAVI Alliance Offices, Geneva, Switzerland


FINAL MINUTES

1. Chair?s report

1.1 Finding a quorum of members present, the meeting commenced at 9. 40
Geneva time on 23 April 2012. Gustavo Gonzalez -Canali , Programme and
Policy Committee Chair , chaired the meeting .

1.2 The Chair welcomed new members attending a PPC meeting for the first time.

1.3 Standing declarations of interest were tabled to the Committee (Doc 01a in
the Committee pack). Anne Schuchat informed the Committee that she would
not vote on the approval of funding under item 9 as a research group from
CDC was involved.

1. 4 The Chair referred briefly to the Board retreat which had been held the
previous week in Oslo, Norway, commenting that there had been useful open
and frank discussion.

------

2. Update from the Secretariat

2.1 Seth Berkley , CEO, gave a report from the Secretariat highlighting the
discussions at the Board retrea t. The key issue for GAVI during this period is
to deliver on the Strategic Plan 2011 -2015. The discussions during the first
day of the retreat were the beginning of a process on what strategic planning
might look like for the next period. A range of potential options had been
discussed and PPC members were encouraged to read the relevant paper if
they had not yet had a chance to do so. One of the issues which will go to the
Board for a decision in June relates to GAVI?s role in measles immunisation.

2. 2 The CEO reported that during the second day of the retreat McKinsey &
Company had presented their report on the Board self -evaluation. The Board
used this report as the ba sis for a useful discussion on the roles and
responsibilities of the different actors in the GAVI governance structure. The
role and composition of the PPC received particular attention and this and
other issues arising during the discussion will be taken up by the Governance
Committee to take forward to the Board in June and/or December.